The Brazilian team dosed a batch of these mini-brains (also known as cerebral organoids) with a compound called 5-MeO-DMT, then used mass spectrometry to analyze how the molecule affected the expression of different proteins in the cerebral models.
They found that the drug upregulated certain proteins and downregulated others, affecting almost 1,000 proteins in all.
Instead, the researchers say their findings highlight that further study is needed to determine just how its benefits could be developed into a potential treatment for mental illnesses and other brain disorders.
Stevens Rehen, lead researcher on the study stated:
"For the first time we could describe psychedelic related changes in the molecular functioning of human neural tissue, our study reinforces the hidden clinical potential of substances that are under legal restrictions, but which deserve attention of medical and scientific communities."
DMT (Dimethyltryptamine) is a hallucinogenic tryptamine drug that occurs naturally in many plants and animals.
It is a class A drug which means that it's illegal to have for yourself, give away or sell although a number of indigenous people’s traditions and religions use drinks or food, such as ayahuasca, that contain DMT.
It is also referred to as the "spirit molecule" due to the intense psychedelic experience.